Voloridge Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.1M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $2.08M | Sell |
|
|||||
|
2024
Q3 | $7.81M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $3.02M | Sell |
|
|||||
|
2023
Q4 | $45.5M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.44M | Sell |
|
|||||
|
2023
Q1 | $2.99M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1M | Sell |
|
|||||
|
2022
Q2 | $9M | Sell |
|
|||||
|
2022
Q1 | $23.8M | Buy |
|
|||||
|
2021
Q4 | $16.3M | Buy |
|
|||||
|
2021
Q3 | $305K | Sell |
|
|||||
|
2021
Q2 | $742K | Sell |
|
|||||
|
2021
Q1 | $5.03M | Buy |
|
|||||
|
2020
Q4 | $4.47M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $3.63M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $1.79M | Buy |
|